Treatment of Takayasu arteritis in Belarus is a comprehensive, multi-stage process aimed at suppressing chronic granulomatous inflammation of the aorta and its major branches. Given the systemic nature of the disease and the high risk of vascular complications, management requires a multidisciplinary approach involving a rheumatologist, cardiologist, and vascular surgeon, as well as the use of modern immunosuppressive and biological therapies.
What Takayasu arteritis is
Takayasu arteritis is a large-vessel vasculitis that predominantly affects the aortic arch, its main branches, and the pulmonary artery. As a result of immune-mediated inflammation, the vessel wall becomes thickened and rigid, leading to stenosis, occlusions, and aneurysmal changes.
Diagnosis is challenging because early manifestations are nonspecific and may include low-grade fever, fatigue, arthralgia, and weight loss. In later stages, ischemic symptoms develop, such as diminished or absent pulses, blood pressure differences between arms, syncope, and ischemic pain affecting the limbs or the brain.
How Takayasu arteritis is treated in Belarus
Medical therapy
At the initial stage, intensive anti-inflammatory treatment is prescribed to control active vasculitis:
- glucocorticoids in individually tailored doses;
- cytotoxic agents (methotrexate, azathioprine, cyclophosphamide) in cases of high disease activity;
- genetically engineered biological agents used when standard therapy is ineffective.
Modern Belarusian clinics follow international treatment protocols, allowing achievement of remission and prevention of irreversible vascular damage.
Surgical and endovascular methods
In the presence of significant stenosis or occlusion, reconstructive interventions may be required:
- endovascular balloon angioplasty;
- stent implantation using modern self-expanding stents;
- aortocoronary or peripheral bypass surgery in cases of critical blood flow impairment;
- surgical correction of aortic aneurysms.
The decision to perform surgery is made after assessing inflammatory activity; interventions are preferably carried out during remission to minimize the risk of complications.
Long-term follow-up
Takayasu arteritis requires prolonged dynamic monitoring:
- regular vascular ultrasound, CTA, or MRA;
- monitoring of inflammatory markers;
- blood pressure control;
- therapy adjustment at the earliest signs of relapse.
In Belarus, structured follow-up protocols are in place to ensure early detection of complications and maintenance of stable remission.
Advantages of treating Takayasu arteritis in Belarus
- use of modern immunosuppressive and biological treatment regimens;
- experienced rheumatologists and vascular surgeons managing rare forms of vasculitis;
- access to high-precision diagnostic methods such as CTA, MRA, and PET-CT;
- integrated multidisciplinary approach;
- possibility of long-term follow-up and therapy adjustment within a single medical center.
Treatment of Takayasu arteritis is provided in leading medical centers in Belarus, where contemporary strategies are applied to control inflammation and restore patency of major vessels.
